# Privium Fund Management B.V.

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1795097. Source: https://holderbook.com/funds/1795097-privium-fund-management-b-v/

- Reported value: $544.2M
- Positions: 61
- Weight of the ten largest: 61.8%
- Filed: 2026-08-07

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| TESLA INC | [TSLA](https://holderbook.com/stocks/TSLA/) | $95.9M | 228,000 | 17.6% | 15 |
| SHOPIFY INC | [SHOP](https://holderbook.com/stocks/SHOP/) | $42.2M | 370,000 | 7.8% | 19 |
| ADVANCED MICRO DEVICES INC | [AMD](https://holderbook.com/stocks/AMD/) | $36.0M | 62,000 | 6.6% | 4 |
| AMAZON COM INC | [AMZN](https://holderbook.com/stocks/AMZN/) | $33.4M | 140,000 | 6.1% | 16 |
| IONIS PHARMACEUTICALS INC | [IONS](https://holderbook.com/stocks/IONS/) | $25.4M | 319,924 | 4.7% | 19 |
| SPOTIFY TECHNOLOGY S A | [SPOT](https://holderbook.com/stocks/SPOT/) | $25.3M | 55,000 | 4.6% | 19 |
| PALANTIR TECHNOLOGIES INC | [PLTR](https://holderbook.com/stocks/PLTR/) | $23.3M | 200,000 | 4.3% | 13 |
| ARROWHEAD PHARMACEUTICALS IN | [ARWR](https://holderbook.com/stocks/ARWR/) | $19.1M | 234,222 | 3.5% | 19 |
| OPENDOOR TECHNOLOGIES INC | [OPEN](https://holderbook.com/stocks/OPEN/) | $18.2M | 3,940,904 | 3.3% | 1 |
| LEMONADE INC | [LMND](https://holderbook.com/stocks/LMND/) | $17.6M | 270,259 | 3.2% | 4 |
| NVIDIA CORPORATION | [NVDA](https://holderbook.com/stocks/NVDA/) | $16.2M | 81,000 | 3.0% | 14 |
| IREN LIMITED | [IREN](https://holderbook.com/stocks/IREN/) | $15.6M | 340,150 | 2.9% | 4 |
| UNIQURE NV | [QURE](https://holderbook.com/stocks/QURE/) | $15.1M | 328,322 | 2.8% | 19 |
| CEREBRAS SYSTEMS INC | [CBRS](https://holderbook.com/stocks/CBRS/) | $13.4M | 60,500 | 2.5% | 1 |
| AST SPACEMOBILE INC | [ASTS](https://holderbook.com/stocks/ASTS/) | $12.9M | 145,000 | 2.4% | 4 |
| ULTRAGENYX PHARMACEUTICAL IN | [RARE](https://holderbook.com/stocks/RARE/) | $11.3M | 338,800 | 2.1% | 19 |
| ARCUTIS BIOTHERAPEUTICS INC | [ARQT](https://holderbook.com/stocks/ARQT/) | $10.5M | 399,367 | 1.9% | 7 |
| BIOGEN INC | [BIIB](https://holderbook.com/stocks/BIIB/) | $10.5M | 48,400 | 1.9% | 5 |
| PROQR THRAPEUTICS N V | [PRQR](https://holderbook.com/stocks/PRQR/) | $10.3M | 5,520,024 | 1.9% | 19 |
| AXSOME THERAPEUTICS INC | [AXSM](https://holderbook.com/stocks/AXSM/) | $9.8M | 39,944 | 1.8% | 14 |
| UROGEN PHARMA LTD | [URGN](https://holderbook.com/stocks/URGN/) | $7.7M | 210,000 | 1.4% | 7 |
| SPACE EXPLORATION TECHN CORP | [SPCX](https://holderbook.com/stocks/SPCX/) | $6.8M | 40,000 | 1.3% | 1 |
| DENALI THERAPEUTICS INC | [DNLI](https://holderbook.com/stocks/DNLI/) | $5.9M | 229,857 | 1.1% | 2 |
| VERTEX PHARMACEUTICALS INC | [VRTX](https://holderbook.com/stocks/VRTX/) | $4.7M | 9,400 | 0.9% | 6 |
| BIOMARIN PHARMACEUTICAL INC | [BMRN](https://holderbook.com/stocks/BMRN/) | $4.3M | 75,000 | 0.8% | 2 |
| KRYSTAL BIOTECH INC | [KRYS](https://holderbook.com/stocks/KRYS/) | $4.2M | 11,170 | 0.8% | 18 |
| ALNYLAM PHARMACEUTICALS INC | [ALNY](https://holderbook.com/stocks/ALNY/) | $3.4M | 11,372 | 0.6% | 2 |
| VIRIDIAN THERAPEUTICS INC | [VRDN](https://holderbook.com/stocks/VRDN/) | $3.2M | 173,516 | 0.6% | 3 |
| BIONTECH SE | [BNTX](https://holderbook.com/stocks/BNTX/) | $2.8M | 30,100 | 0.5% | 5 |
| HIMS & HERS HEALTH INC | [HIMS](https://holderbook.com/stocks/HIMS/) | $2.8M | 80,000 | 0.5% | 5 |
| MEIRAGTX HLDGS PLC | [MGTX](https://holderbook.com/stocks/MGTX/) | $2.6M | 196,112 | 0.5% | 10 |
| AMBEV SA | [ABEV](https://holderbook.com/stocks/ABEV/) | $2.5M | 802,167 | 0.5% | 18 |
| SAREPTA THERAPEUTICS INC | [SRPT](https://holderbook.com/stocks/SRPT/) | $2.5M | 136,500 | 0.5% | 3 |
| CRISPR THERAPEUTICS AG | [CRSP](https://holderbook.com/stocks/CRSP/) | $2.5M | 44,974 | 0.5% | 14 |
| BEAM THERAPEUTICS INC | [BEAM](https://holderbook.com/stocks/BEAM/) | $2.4M | 70,282 | 0.4% | 4 |
| ZAI LAB LTD | [ZLAB](https://holderbook.com/stocks/ZLAB/) | $2.3M | 122,189 | 0.4% | 19 |
| MODERNA INC | [MRNA](https://holderbook.com/stocks/MRNA/) | $2.1M | 29,994 | 0.4% | 18 |
| CARTESIAN THERAPEUTICS INC | [RNAC](https://holderbook.com/stocks/RNAC/) | $1.6M | 151,675 | 0.3% | 3 |
| MAGNUM ICE CREAM CO NV | [MICC](https://holderbook.com/stocks/MICC/) | $1.5M | 98,221 | 0.3% | 1 |
| WAVE LIFE SCIENCES LTD | [WVE](https://holderbook.com/stocks/WVE/) | $1.4M | 241,010 | 0.3% | 8 |
| TAYSHA GENE THERAPIES INC | [TSHA](https://holderbook.com/stocks/TSHA/) | $1.4M | 198,900 | 0.2% | 9 |
| ZOETIS INC | [ZTS](https://holderbook.com/stocks/ZTS/) | $1.2M | 17,322 | 0.2% | 1 |
| 4D MOLECULAR THERAPEUTICS IN | [FDMT](https://holderbook.com/stocks/FDMT/) | $1.2M | 90,110 | 0.2% | 12 |
| FATE THERAPEUTICS INC | [FATE](https://holderbook.com/stocks/FATE/) | $1.1M | 414,311 | 0.2% | 8 |
| LEGEND BIOTECH CORP | [LEGN](https://holderbook.com/stocks/LEGN/) | $1.0M | 35,400 | 0.2% | 1 |
| ROCKET PHARMACEUTICALS INC | [RCKT](https://holderbook.com/stocks/RCKT/) | $835.0K | 244,146 | 0.2% | 17 |
| NOV INC | [NOV](https://holderbook.com/stocks/NOV/) | $779.6K | 42,026 | 0.1% | 19 |
| B2GOLD CORP | [BTG](https://holderbook.com/stocks/BTG/) | $729.6K | 195,083 | 0.1% | 2 |
| TOTALENERGIES SE | [TTE](https://holderbook.com/stocks/TTE/) | $729.5K | 10,723 | 0.1% | 1 |
| LEXEO THERAPEUTICS INC | [LXEO](https://holderbook.com/stocks/LXEO/) | $722.3K | 155,000 | 0.1% | 7 |
| TRANSOCEAN LTD | [RIG](https://holderbook.com/stocks/RIG/) | $712.0K | 145,604 | 0.1% | 4 |
| MOLINA HEALTHCARE INC | [MOH](https://holderbook.com/stocks/MOH/) | $681.3K | 2,979 | 0.1% | 2 |
| NU HLDGS LTD | [NU](https://holderbook.com/stocks/NU/) | $587.8K | 44,000 | 0.1% | 1 |
| AUTOLUS THERAPEUTICS LTD | [AUTL](https://holderbook.com/stocks/AUTL/) | $581.5K | 363,430 | 0.1% | 18 |
| TIDEWATER INC NEW | [TDW](https://holderbook.com/stocks/TDW/) | $578.5K | 8,683 | 0.1% | 5 |
| LULULEMON ATHLETICA INC | [LULU](https://holderbook.com/stocks/LULU/) | $578.1K | 5,063 | 0.1% | 1 |
| SANDRIDGE ENERGY INC | [SD](https://holderbook.com/stocks/SD/) | $531.5K | 38,792 | 0.1% | 9 |
| SEABRIDGE GOLD INC | - | $425.0K | 16,512 | 0.1% | 1 |
| VOYAGER THERAPEUTICS INC | [VYGR](https://holderbook.com/stocks/VYGR/) | $420.0K | 120,000 | 0.1% | 6 |
| Engene Therapeutics Inc | [ENGN](https://holderbook.com/stocks/ENGN/) | $294.1K | 170,000 | 0.1% | 1 |
| COSAN S A | [CSAN](https://holderbook.com/stocks/CSAN/) | $149.8K | 52,000 | 0.0% | 1 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +17.2% | +14.8% | +2.4% | 100% |
| Q1 2026 | -14.4% | -4.6% | -9.8% | 100% |
| Q4 2025 | +0.8% | +2.4% | -1.5% | 100% |
| Q3 2025 | +22.6% | +7.8% | +14.8% | 102% |
| Q2 2025 | +27.2% | +10.5% | +16.7% | 100% |
| Q1 2025 | -8.5% | -4.6% | -4.0% | 100% |
| Q4 2024 | +21.6% | +2.1% | +19.4% | 100% |
| Q3 2024 | +8.3% | +5.4% | +2.9% | 97% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $544.2M | 61 |
| Q1 2026 | $480.3M | 60 |
| Q4 2025 | $543.1M | 57 |
| Q3 2025 | $556.3M | 59 |
| Q2 2025 | $463.5M | 55 |
| Q1 2025 | $383.6M | 56 |
| Q4 2024 | $441.9M | 64 |
| Q3 2024 | $402.0M | 82 |
| Q2 2024 | $392.1M | 129 |
| Q1 2024 | $374.5M | 117 |
| Q4 2023 | $359.0M | 114 |
| Q3 2023 | $336.2M | 115 |